| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |